A meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancer
Changyuan Zhang,1,* Jie Li,2,* Yi Han,3 Jian Jiang4 1Department of Cardiothoracic Surgery, Inner Mongolia Autonomous Region People’s Hospital, Inner Mongolia; 2Department of Oncology, 3Department of Thoracic Surgery, Beijing Chest Hospital, 4Department of Thoracic Surgery, Beijing Tongren...
Main Authors: | Zhang C, Li J, Han Y, Jiang J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-06-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/a-meta-analysis-for-cxcr4-as-a-prognostic-marker-and-potential-drug-ta-peer-reviewed-article-DDDT |
Similar Items
-
CXCR3 is a prognostic marker and a potential target for patients with solid tumors: a meta-analysis
by: Zhang Y, et al.
Published: (2018-02-01) -
Advances in Drug Resistance Mechanisms and Prognostic Markers of Targeted Therapy in ALK-positive Non-small Cell Lung Cancer
by: Shasha WANG, et al.
Published: (2020-11-01) -
Clinicopathological significance and potential drug target of RUNX3 in non-small cell lung cancer: a meta-analysis
by: Xu L, et al.
Published: (2015-06-01) -
Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer
by: You Q, et al.
Published: (2015-09-01) -
Clinicopathological significance of CXCR4 in non-small cell lung cancer
by: Zhou X, et al.
Published: (2015-03-01)